Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis.

Khsheibun R, Paperna T, Volkowich A, Lejbkowicz I, Avidan N, Miller A.

PLoS One. 2014 Jul 15;9(7):e102331. doi: 10.1371/journal.pone.0102331. eCollection 2014.

PMID:
25025430
[PubMed - in process]
Free PMC Article
2.

Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.

Irizar H, Muñoz-Culla M, Sepúlveda L, Sáenz-Cuesta M, Prada Á, Castillo-Triviño T, Zamora-López G, de Munain AL, Olascoaga J, Otaegui D.

PLoS One. 2014 Feb 28;9(2):e90482. doi: 10.1371/journal.pone.0090482. eCollection 2014.

PMID:
24587374
[PubMed - in process]
Free PMC Article
3.

Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.

Mellergård J, Edström M, Jenmalm MC, Dahle C, Vrethem M, Ernerudh J.

PLoS One. 2013 Dec 2;8(12):e81685. doi: 10.1371/journal.pone.0081685. eCollection 2013.

PMID:
24312575
[PubMed - in process]
Free PMC Article
4.

Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?

Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu LG, Maida I, Babudieri S, Serra C, Manetti R, Mura MS, Dolei A.

PLoS One. 2013 Nov 13;8(11):e78474. doi: 10.1371/journal.pone.0078474. eCollection 2013.

PMID:
24236019
[PubMed - in process]
Free PMC Article
5.

Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells.

Zandieh A, Izad M, Fakhri M, Amirifard H, Khazaeipour Z, Harirchian MH.

Transl Neurodegener. 2013 Jul 2;2(1):14. doi: 10.1186/2047-9158-2-14.

PMID:
23819946
[PubMed]
Free PMC Article
6.

Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.

Martinez-Pasamar S, Abad E, Moreno B, Velez de Mendizabal N, Martinez-Forero I, Garcia-Ojalvo J, Villoslada P.

BMC Syst Biol. 2013 Apr 26;7:34. doi: 10.1186/1752-0509-7-34.

PMID:
23618467
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.

Brown JW, Coles AJ.

Drug Des Devel Ther. 2013;7:131-8. doi: 10.2147/DDDT.S32687. Epub 2013 Mar 6. Review.

PMID:
23494602
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Pierrot-Deseilligny C, Souberbielle JC.

Ther Adv Neurol Disord. 2013 Mar;6(2):81-116. doi: 10.1177/1756285612473513.

PMID:
23483715
[PubMed]
Free PMC Article
9.

What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?

Buzzard KA, Broadley SA, Butzkueven H.

Int J Mol Sci. 2012 Oct 4;13(10):12665-709. doi: 10.3390/ijms131012665.

PMID:
23202920
[PubMed]
Free PMC Article
10.

Vitamin D receptor binding, chromatin states and association with multiple sclerosis.

Disanto G, Sandve GK, Berlanga-Taylor AJ, Ragnedda G, Morahan JM, Watson CT, Giovannoni G, Ebers GC, Ramagopalan SV.

Hum Mol Genet. 2012 Aug 15;21(16):3575-86. doi: 10.1093/hmg/dds189. Epub 2012 May 16.

PMID:
22595971
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk